Business Description
Nextage Therapeutics Ltd
ISIN : IL0004330119
Total Employee Number:
18Compare
Compare
Traded in other countries / regions
NXTG.Israel IPO Date
1993-05-27Description
Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.22 | |||||
Debt-to-EBITDA | -1.81 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.08 | |||||
Beneish M-Score | -2.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.9 | |||||
3-Year EPS without NRI Growth Rate | 11.6 | |||||
3-Year FCF Growth Rate | 28.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.37 | |||||
9-Day RSI | 46.97 | |||||
14-Day RSI | 46.3 | |||||
3-1 Month Momentum % | -2.91 | |||||
6-1 Month Momentum % | -44.29 | |||||
12-1 Month Momentum % | -57.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.06 | |||||
Cash Ratio | 0.01 | |||||
Days Sales Outstanding | 56.81 | |||||
Days Payable | 309 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -42.5 | |||||
Shareholder Yield % | -36.12 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 8.28 | |||||
Operating Margin % | -226.46 | |||||
Net Margin % | -168.48 | |||||
EBITDA Margin % | -266.34 | |||||
FCF Margin % | -180.82 | |||||
OCF Margin % | -180.82 | |||||
ROE % | -122.93 | |||||
ROA % | -18.87 | |||||
ROIC % | -17.79 | |||||
3-Year ROIIC % | -3.63 | |||||
ROC (Joel Greenblatt) % | -726.89 | |||||
ROCE % | -139.19 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.34 | |||||
PB Ratio | 2.18 | |||||
EV-to-EBIT | -4.34 | |||||
EV-to-EBITDA | -5.05 | |||||
EV-to-Revenue | 13.44 | |||||
EV-to-FCF | -7.47 | |||||
Price-to-GF-Value | 1.26 | |||||
Earnings Yield (Greenblatt) % | -23.1 | |||||
FCF Yield % | -20.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nextage Therapeutics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 3.598 | ||
| EPS (TTM) (₪) | -0.032 | ||
| Beta | 0.1018 | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.13 | ||
| Volatility % | 32.84 | ||
| 14-Day RSI | 46.3 | ||
| 14-Day ATR (₪) | 0.033576 | ||
| 20-Day SMA (₪) | 0.3949 | ||
| 12-1 Month Momentum % | -57.86 | ||
| 52-Week Range (₪) | 0.062 - 1.03 | ||
| Shares Outstanding (Mil) | 81.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nextage Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nextage Therapeutics Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| 0.05:1 Stock Split | 2020-04-12 | 6.22 (+0.00%) |
Show
Entries
Nextage Therapeutics Ltd Frequently Asked Questions
What is Nextage Therapeutics Ltd(XTAE:NXTG)'s stock price today?
The current price of XTAE:NXTG is ₪0.39. The 52 week high of XTAE:NXTG is ₪1.03 and 52 week low is ₪0.06.
When is next earnings date of Nextage Therapeutics Ltd(XTAE:NXTG)?
The next earnings date of Nextage Therapeutics Ltd(XTAE:NXTG) is .
Does Nextage Therapeutics Ltd(XTAE:NXTG) pay dividends? If so, how much?
Nextage Therapeutics Ltd(XTAE:NXTG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nextage Therapeutics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers